Page 1 of 132
GEORGETTE'S LMR PMHNP CERTIFICATION EXAM QUESTIONS
AND CORRECT VERIFIED SOLUTIONS LATEST UPDATE THIS
YEAR – JUST RELEASED
GEORGETTE'S LMR PMHNP CERTIFICATION EXAM
10-Line Exam Coverage in Points Form
1. Scientific Foundations – Neuroanatomy and neurophysiology; neurotransmitter systems
(dopamine, serotonin, norepinephrine, GABA); pathophysiology of psychiatric disorders;
psychiatric and medical comorbidities; epidemiology
2. Psychopharmacology – Pharmacodynamics and pharmacokinetics; antipsychotics
(typical vs. atypical); antidepressants (SSRIs, SNRIs, MAOIs, TCAs); mood stabilizers
(lithium, anticonvulsants); anxiolytics; medication monitoring and polypharmacy
3. Neuroleptic Malignant Syndrome (NMS) vs. Serotonin Syndrome (SS) – Onset
differences (NMS: 1-2 weeks, SS: within 24 hours); key symptoms (NMS: rigidity,
hyperthermia, elevated CPK; SS: hyperreflexia, myoclonus, shits and shivers); treatment
(NMS: bromocriptine + dantrolene; SS: cyproheptadine)
4. Clozapine & High-Risk Medications – Treatment-resistant schizophrenia; agranulocytosis
monitoring (WBC <2000 or ANC <1000 requires discontinuation); fever + sore throat =
red flag; CBC with differential priority; highest risk of agranulocytosis: Clozaril and
Tegretol
5. Lithium Management – Therapeutic levels (0.6-1.2 mEq/L); toxicity signs (tremor,
diarrhea, vomiting, confusion); level >3.0 = medical emergency; drug interactions
(NSAIDs, ACE inhibitors increase toxicity; CCBs = fatal nephrotoxicity); Ebstein's anomaly
in pregnancy; check EKG for inverted T-waves
6. Depakote & Lamictal Interactions – Depakote decreases lamotrigine metabolism;
reduce lamotrigine dose by 50% when combined; Depakote in pregnancy = spina bifida;
upper abdominal pain = pancreatitis (check lipase); RUQ pain + dark urine = check LFTs;
slow titration for lamotrigine prevents Stevens-Johnson syndrome
7. Assessment & Diagnostic Skills – Clinical interviewing and MSE; diagnostic decision-
making using DSM-5-TR; risk assessment and safety planning; least restrictive
interventions; trauma-informed care; screening tools; ADPIE framework (Assessment,
Diagnosis, Planning, Implementation, Evaluation)
8. Psychotherapies & Treatment Modalities – CBT vs. Cognitive Therapy (CBT has
behavioral component); DBT for borderline personality disorder; Interpersonal Therapy
(individual and group); psychotherapeutic foundations; family and group therapy
theories
, Page 2 of 132
9. Ethics, Legal & Cultural Care – Scope and standards; ANA Scope and Standards of
Practice; professional boundaries; confidentiality and informed consent; cultural
awareness and humility; implicit biases; vulnerable populations
10. Lifespan & Special Populations – Infant/child (6%), pre-adolescent (8%), adolescent
(16%), adult (50%), older adult (20%); pregnancy considerations; geriatric mental health;
child/adolescent neurodevelopmental disorders; developmental-appropriate care
practices
COMPREHENSIVE PRACTICE QUESTIONS
Section 1: Scientific Foundations
1. A patient with schizophrenia presents with auditory hallucinations and delusions of
persecution. Which neurotransmitter pathway is MOST associated with these positive
symptoms?
A) Mesocortical dopamine pathway
B) Mesolimbic dopamine pathway
C) Nigrostriatal dopamine pathway
D) Tuberoinfundibular dopamine pathway
Answer: B
Rationale: Positive symptoms of schizophrenia (hallucinations, delusions, disorganized thinking)
are associated with hyperactivity of the mesolimbic dopamine pathway. This pathway projects
from the ventral tegmental area to the limbic system (nucleus accumbens, amygdala,
hippocampus). The mesocortical pathway (A) is associated with negative symptoms
, Page 3 of 132
(hypofrontality). Nigrostriatal pathway (C) is associated with motor function and EPS.
Tuberoinfundibular pathway (D) regulates prolactin release .
2. A patient on an antipsychotic develops extrapyramidal symptoms. Which dopamine
pathway is affected by D2 receptor blockade leading to these side effects?
A) Mesocortical pathway
B) Mesolimbic pathway
C) Nigrostriatal pathway
D) Tuberoinfundibular pathway
Answer: C
Rationale: EPS results from D2 receptor blockade in the nigrostriatal pathway, which normally
inhibits the indirect pathway to regulate motor control. This is why first-generation
antipsychotics have higher EPS risk. Tuberoinfundibular blockade causes hyperprolactinemia.
Mesolimbic blockade treats positive symptoms. Mesocortical blockade contributes to negative
symptoms.
3. Which statement correctly describes the pathophysiology of Major Depressive Disorder?
A) Primarily caused by excess dopamine in the limbic system
B) Monoamine hypothesis proposes deficiency of serotonin, norepinephrine, and/or dopamine
C) GABA deficiency is the primary mechanism
D) Excess acetylcholine in the hippocampus
Answer: B
, Page 4 of 132
Rationale: The monoamine hypothesis of depression proposes that depression results from
deficiency of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) in key brain
regions. This is supported by the mechanism of antidepressants (SSRIs, SNRIs, MAOIs). GABA
deficiency (C) is associated with anxiety disorders. Excess dopamine (A) is associated with
schizophrenia.
4. A patient with treatment-resistant depression is started on an MAOI. Which dietary
restriction is essential to prevent hypertensive crisis?
A) Limit caffeine intake
B) Avoid tyramine-containing foods (aged cheese, cured meats, fermented products)
C) Avoid high-sodium foods
D) Limit protein intake
Answer: B
Rationale: MAOIs inhibit monoamine oxidase, preventing breakdown of tyramine. Tyramine-rich
foods can cause massive norepinephrine release leading to hypertensive crisis. Foods to avoid
include aged cheese, cured meats, fermented products, and certain wines. Caffeine (A) and
sodium (C, D) are not the primary concern.
5. The 5-HT1A receptor is a target for which medication class?
A) SSRIs
B) SNRIs
GEORGETTE'S LMR PMHNP CERTIFICATION EXAM QUESTIONS
AND CORRECT VERIFIED SOLUTIONS LATEST UPDATE THIS
YEAR – JUST RELEASED
GEORGETTE'S LMR PMHNP CERTIFICATION EXAM
10-Line Exam Coverage in Points Form
1. Scientific Foundations – Neuroanatomy and neurophysiology; neurotransmitter systems
(dopamine, serotonin, norepinephrine, GABA); pathophysiology of psychiatric disorders;
psychiatric and medical comorbidities; epidemiology
2. Psychopharmacology – Pharmacodynamics and pharmacokinetics; antipsychotics
(typical vs. atypical); antidepressants (SSRIs, SNRIs, MAOIs, TCAs); mood stabilizers
(lithium, anticonvulsants); anxiolytics; medication monitoring and polypharmacy
3. Neuroleptic Malignant Syndrome (NMS) vs. Serotonin Syndrome (SS) – Onset
differences (NMS: 1-2 weeks, SS: within 24 hours); key symptoms (NMS: rigidity,
hyperthermia, elevated CPK; SS: hyperreflexia, myoclonus, shits and shivers); treatment
(NMS: bromocriptine + dantrolene; SS: cyproheptadine)
4. Clozapine & High-Risk Medications – Treatment-resistant schizophrenia; agranulocytosis
monitoring (WBC <2000 or ANC <1000 requires discontinuation); fever + sore throat =
red flag; CBC with differential priority; highest risk of agranulocytosis: Clozaril and
Tegretol
5. Lithium Management – Therapeutic levels (0.6-1.2 mEq/L); toxicity signs (tremor,
diarrhea, vomiting, confusion); level >3.0 = medical emergency; drug interactions
(NSAIDs, ACE inhibitors increase toxicity; CCBs = fatal nephrotoxicity); Ebstein's anomaly
in pregnancy; check EKG for inverted T-waves
6. Depakote & Lamictal Interactions – Depakote decreases lamotrigine metabolism;
reduce lamotrigine dose by 50% when combined; Depakote in pregnancy = spina bifida;
upper abdominal pain = pancreatitis (check lipase); RUQ pain + dark urine = check LFTs;
slow titration for lamotrigine prevents Stevens-Johnson syndrome
7. Assessment & Diagnostic Skills – Clinical interviewing and MSE; diagnostic decision-
making using DSM-5-TR; risk assessment and safety planning; least restrictive
interventions; trauma-informed care; screening tools; ADPIE framework (Assessment,
Diagnosis, Planning, Implementation, Evaluation)
8. Psychotherapies & Treatment Modalities – CBT vs. Cognitive Therapy (CBT has
behavioral component); DBT for borderline personality disorder; Interpersonal Therapy
(individual and group); psychotherapeutic foundations; family and group therapy
theories
, Page 2 of 132
9. Ethics, Legal & Cultural Care – Scope and standards; ANA Scope and Standards of
Practice; professional boundaries; confidentiality and informed consent; cultural
awareness and humility; implicit biases; vulnerable populations
10. Lifespan & Special Populations – Infant/child (6%), pre-adolescent (8%), adolescent
(16%), adult (50%), older adult (20%); pregnancy considerations; geriatric mental health;
child/adolescent neurodevelopmental disorders; developmental-appropriate care
practices
COMPREHENSIVE PRACTICE QUESTIONS
Section 1: Scientific Foundations
1. A patient with schizophrenia presents with auditory hallucinations and delusions of
persecution. Which neurotransmitter pathway is MOST associated with these positive
symptoms?
A) Mesocortical dopamine pathway
B) Mesolimbic dopamine pathway
C) Nigrostriatal dopamine pathway
D) Tuberoinfundibular dopamine pathway
Answer: B
Rationale: Positive symptoms of schizophrenia (hallucinations, delusions, disorganized thinking)
are associated with hyperactivity of the mesolimbic dopamine pathway. This pathway projects
from the ventral tegmental area to the limbic system (nucleus accumbens, amygdala,
hippocampus). The mesocortical pathway (A) is associated with negative symptoms
, Page 3 of 132
(hypofrontality). Nigrostriatal pathway (C) is associated with motor function and EPS.
Tuberoinfundibular pathway (D) regulates prolactin release .
2. A patient on an antipsychotic develops extrapyramidal symptoms. Which dopamine
pathway is affected by D2 receptor blockade leading to these side effects?
A) Mesocortical pathway
B) Mesolimbic pathway
C) Nigrostriatal pathway
D) Tuberoinfundibular pathway
Answer: C
Rationale: EPS results from D2 receptor blockade in the nigrostriatal pathway, which normally
inhibits the indirect pathway to regulate motor control. This is why first-generation
antipsychotics have higher EPS risk. Tuberoinfundibular blockade causes hyperprolactinemia.
Mesolimbic blockade treats positive symptoms. Mesocortical blockade contributes to negative
symptoms.
3. Which statement correctly describes the pathophysiology of Major Depressive Disorder?
A) Primarily caused by excess dopamine in the limbic system
B) Monoamine hypothesis proposes deficiency of serotonin, norepinephrine, and/or dopamine
C) GABA deficiency is the primary mechanism
D) Excess acetylcholine in the hippocampus
Answer: B
, Page 4 of 132
Rationale: The monoamine hypothesis of depression proposes that depression results from
deficiency of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) in key brain
regions. This is supported by the mechanism of antidepressants (SSRIs, SNRIs, MAOIs). GABA
deficiency (C) is associated with anxiety disorders. Excess dopamine (A) is associated with
schizophrenia.
4. A patient with treatment-resistant depression is started on an MAOI. Which dietary
restriction is essential to prevent hypertensive crisis?
A) Limit caffeine intake
B) Avoid tyramine-containing foods (aged cheese, cured meats, fermented products)
C) Avoid high-sodium foods
D) Limit protein intake
Answer: B
Rationale: MAOIs inhibit monoamine oxidase, preventing breakdown of tyramine. Tyramine-rich
foods can cause massive norepinephrine release leading to hypertensive crisis. Foods to avoid
include aged cheese, cured meats, fermented products, and certain wines. Caffeine (A) and
sodium (C, D) are not the primary concern.
5. The 5-HT1A receptor is a target for which medication class?
A) SSRIs
B) SNRIs
